Winston Pharmaceuticals, Inc.
WPHM · OTC
12/31/2009 | 12/31/2008 | 9/30/2007 | 9/30/2006 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.03 | -0.04 | 0.01 | -0.00 |
| FCF Yield | -76.17% | -64.03% | -116.55% | -193.61% |
| EV / EBITDA | -1.45 | 0.16 | 21.67 | -0.73 |
| Quality | ||||
| ROIC | -561.07% | -161.95% | 0.00% | 0.00% |
| Gross Margin | 99.35% | 98.09% | 0.00% | 0.00% |
| Cash Conversion Ratio | 1.58 | 0.60 | 0.96 | 0.23 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | -100.00% |
| Free Cash Flow Growth | -36.42% | -1,679.61% | -63.56% | -183.78% |
| Safety | ||||
| Net Debt / EBITDA | 0.57 | 1.08 | 22.41 | -0.60 |
| Interest Coverage | 0.00 | 0.00 | 0.00 | -10.82 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | -29,335.12 | -44,635.24 | 0.00 | -223.40 |